Zenas BioPharma, Inc. (ZBIO)

28.3 USDclose 2026-10-02Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$1.92B52 Week Range: 28.3 – 28.3
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -10.05
The live quote provider is unreachable; the last known close is shown.

Zenas BioPharma, Inc. (ZBIO) is not among the 30 most-held stocks of the tracked superinvestor set. Price 28.30 USD; market cap $1.92B.

Price & valuation

Prev Close—
Open—
Day Range—
52 Week Range28.3 – 28.3
Volume—
Avg Volume (3M)—
Market Cap$1.92BSEC 10-Q, 10/30/2026
BetaVolatility vs the market. Above 1: swings harder than the index.—
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.-10.05SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own ZBIO?

Zenas BioPharma, Inc. (ZBIO) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on ZBIO bullish or bearish?

ZBIO is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.